SureshGNairMD

Oncology • Allentown, PA

Medical Oncologist, Lehigh Valley Hospital

Join to view full profile

Dr. Nair is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Nair's full profile

Already have an account?

Office
1240 S Cedar Crest Blvd
Suite 401
Allentown, PA 18103
Phone+1 610-402-7880
Is this information wrong?

Education & Training

UPMC Medical EducationFellowship, Hematology and Medical Oncology, 1987 - 1990
Geisinger Health System (Danville)Residency, Internal Medicine, 1984 - 1987
Sidney Kimmel Medical College at Thomas Jefferson UniversityClass of 1984

Certifications & Licensure

PA State Medical License 1985 - 2024
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

Patient-Centered Specialty Practice Recognition Program National Committee for Quality Assurance, 2014-2017
Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2012

Clinical Trials

Imatinib Mesylate in Treating Patients With Recurrent Brain Tumor Start of enrollment: 2003 Jun 01
Completed
Phase 1, Phase 2
Sorafenib Tosylate and Temsirolimus in Treating Patients With Recurrent Glioblastoma Start of enrollment: 2006 Mar 24
Completed
Phase 1, Phase 2
Everolimus, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Start of enrollment: 2009 Mar 01
Completed
Phase 1, Phase 2
Capecitabine and Lapatinib Ditosylate With or Without Cixutumumab in Treating Patients With Previously Treated HER2-Positive Stage IIIB-IV Breast Cancer Start of enrollment: 2008 Jul 30
Completed
Phase 2
Radiation Therapy With Concomitant and Adjuvant Temozolomide Versus Radiation Therapy With Adjuvant PCV Chemotherapy in Patients With Anaplastic Glioma or Low Grade Glioma Start of enrollment: 2009 Sep 01
Recruiting
Phase 3
Docetaxel, Oxaliplatin, Capecitabine, Fluorouracil, and Radiation Therapy in Treating Patients With Locally Advanced Cancer of the Esophagus or Gastroesophageal Junction Start of enrollment: 2010 Jan 01
Completed
Phase 2
Carboplatin, Paclitaxel, and Bevacizumab With or Without Everolimus in Treating Patients With Metastatic Malignant Melanoma Start of enrollment: 2010 Apr 01
Completed
Phase 2
Calcium Gluconate and Magnesium Sulfate in Preventing Neurotoxicity in Patients With Colon Cancer or Rectal Cancer Receiving Oxaliplatin-Based Combination Chemotherapy Start of enrollment: 2010 Jun 01
Completed
Phase 3
S0931, Everolimus in Treating Patients With Kidney Cancer Who Have Undergone Surgery Start of enrollment: 2011 Apr 01
Active, not recruiting
Phase 3
Doxepin Hydrochloride in Treating Oral Mucositis Pain in Patients With Head and Neck Cancer Undergoing Radiation Therapy With or Without Chemotherapy Start of enrollment: 2010 Dec 01
Completed
Phase 3
Rituximab and Bendamustine Hydrochloride, Rituximab and Ibrutinib, or Ibrutinib Alone in Treating Older Patients With Previously Untreated Chronic Lymphocytic Leukemia Start of enrollment: 2013 Dec 09
Active, not recruiting
Phase 3
An Open-Label, Randomized, Phase 3 Trial of Nivolumab Versus Investigator's Choice Chemotherapy as First-Line Therapy for Stage IV or Recurrent PD-L1+ Non-Small Cell Lung Cancer (CheckMate 026) Start of enrollment: 2014 Mar 27
Completed
Phase 3
Study of Nivolumab in Patients With Classical Hodgkin's Lymphoma (Registrational) Start of enrollment: 2014 Aug 12
Completed
Phase 2
A Study of Relatlimab Plus Nivolumab Versus Nivolumab Alone in Participants With Advanced Melanoma Start of enrollment: 2018 Apr 11
Active, not recruiting
Phase 2, Phase 3
Pan Tumor Rollover Study Start of enrollment: 2019 Aug 09
Recruiting
Phase 2
Effectiveness Study of Nivolumab Compared to Placebo in Prevention of Recurrent Melanoma After Complete Resection of Stage IIB/C Melanoma Start of enrollment: 2019 Oct 28
Active, not recruiting
Phase 3
Join now to see all

Publications & Presentations

PubMed

Validation of Immunotherapy Response Score as Predictive of Pan-solid Tumor Anti-PD-1/PD-L1 Benefit.
Benjamin J Bulen, Nickolay A Khazanov, Daniel H Hovelson, Laura E Lamb, Marc Matrana, Mark E Burkard, Eddy Shih-Hsin Yang, William J Edenfield, Elizabeth Claire Dees, ...> ;Cancer Research Communications. 2023 Jul 1
44 citations
Oncolytic DNX-2401 virotherapy plus pembrolizumab in recurrent glioblastoma: a phase 1/2 trial.
Farshad Nassiri, Vikas Patil, Leeor S Yefet, Olivia Singh, Jeff Liu, Rachel M A Dang, Takafumi N Yamaguchi, Mariza Daras, Timothy F Cloughesy, Howard Colman, Priya U K...> ;Nature Medicine. 2023 Jun 1
Immunotherapy May Improve Tumor Sensitivity to Palliative Chemotherapy in Platinum Resistant Ovarian Cancer.
Rachel E Kinney, Suresh Nair, Christine H Kim, M Bijoy Thomas, Martin DelaTorre> ;The Oncologist. 2023 Jun 2
7 citations
Development and validation of an integrative pan-solid tumor predictor of PD-1/PD-L1 blockade benefit.
Tomlins, S., Khazanov, N., Bulen, B., Hovelson, D., Shreve, M., Lamb, L., Matrana, M., Burkard, M., Yang, E., Edenfield, W., Dees, E., Onitilo, A., Thompson, M., Buchs...> ;Communications Medicine. 2023 Feb 7
16 citations
Multicenter Phase II Clinical Trial of Gemcitabine and Cisplatin as Neoadjuvant Chemotherapy for Patients With High-Grade Upper Tract Urothelial Carcinoma.
Jonathan A Coleman, Wesley Yip, Nathan C Wong, Daniel D Sjoberg, Bernard H Bochner, Guido Dalbagni, S Machele Donat, Harry W Herr, Eugene K Cha, Timothy F Donahue, Eug...> ;Journal of Clinical Oncology. 2023 Mar 10
13 citations
FRACTION-RCC: nivolumab plus ipilimumab for advanced renal cell carcinoma after progression on immuno-oncology therapy.
Toni K Choueiri, Harriet Kluger, Saby George, Scott S Tykodi, Timothy M Kuzel, Ruth Perets, Suresh Nair, Giuseppe Procopio, Michael A Carducci, Vincent Castonguay, Edm...> ;Journal for Immunotherapy of Cancer. 2022 Nov 1
172 citations
Hypoxia induces phenotypic plasticity and therapy resistance in melanoma via the tyrosine kinase receptors ROR1 and ROR2
Michael P. O'Connell, Katie Marchbank, Marie R. Webster, Alexander Valiga, Amanpreet Kaur, Adina Vultur, Ling Li, Meenhard Herlyn, Jessie Villanueva, Qin Liu, Xiangfan...> ;Cancer Discovery. 2013 Oct 8
1513 citations
First-Line Nivolumab in Stage IV or Recurrent Non–Small-Cell Lung Cancer
David P. Carbone, Martin Reck, Luis Paz-Ares, Benjamin C. Creelan, Leora Horn, Martin Steins, Enriqueta Felip, Michel M. van den Heuvel, Tudor-Eliade Ciuleanu, Firas B...> ;The New England Journal of Medicine. 2017 Jun 21
3 citations
Current Clinical Trials in the Treatment of Advanced Melanomas.
Saro Sarkisian Md, Suresh G. Nair Md, Rohit Sharma> ;The Surgical Clinics of North America. 2020 Feb 1
Fibroblast Growth Factor Receptor 3 Amplified Metastatic Melanoma Treated With Erdafitinib.
Saro Sarkisian Md, Alyson McIntosh Md, Suresh G. Nair Md, Alexander N. Shoushtari, Margaret K. Callahan> ;Cureus. 2020 Oct 29
2 citations
Dramatic Response to Concurrent Anti‐PD‐1 Therapy and Radiation in Resistant Tumors with Sarcomatoid Differentiation
Sameer Tolay, Alyson McIntosh Md, Dennis M. Sopka, Suresh G. Nair Md> ;The Oncologist. 2019 Jan 1
23 citations
Label-free detection of rare circulating tumor cells by image analysis and machine learning
Shen Wang, Yuyuan Zhou, Xiaochen Qin, Suresh G. Nair Md, Xiaolei Huang, Yaling Liu> ;Scientific Reports. 2020 Jul 22
13 citations
Real-World Performance of a Comprehensive Genomic Profiling Test Optimized for Small Tumor Samples.
Scott A. Tomlins, Daniel H. Hovelson, Jennifer Marie Suga, Daniel M. Anderson, Han A. Koh, Elizabeth Claire Dees, Brendan McNulty, Mark E. Burkard, Michael Guarino, Ja...> ;JCO Precision Oncology. 2021 Aug 19
24 citations
Adaptive Dosing of Nivolumab + Ipilimumab Immunotherapy Based Upon Early, Interim Radiographic Assessment in Advanced Melanoma (The ADAPT-IT Study).
Michael A Postow, Debra A Goldman, Alexander N Shoushtari, Allison Betof Warner, Margaret K Callahan, Parisa Momtaz, James W Smithy, Ellesa Naito, Marina K Cugliari, V...> ;Journal of Clinical Oncology. 2022 Apr 1
3 citations
Case report: response to the ERK1/2 inhibitor ulixertinib in BRAF D594G cutaneous melanoma.
Zachary Wolfe, Julie C Friedland, Sarah Ginn, Aaron Blackham, Lauren Demberger, Morgan Horton, Alyson McIntosh, Hina Sheikh, Jessica Box, Deborah Knoerzer, Bryan Feder...> ;Melanoma Research. 2022 Aug 1
3 citations
Engaging Community-Based Cancer Physicians: Experience of the Memorial Sloan Kettering Cancer Center Cancer Alliance.
Allison Lipitz-Snyderman, Jessica Kennington, Brooke Hogan, Deborah Korenstein, Leonard Kalman, Suresh G. Nair Md, Peter Yu, Paul Sabbatini, David G. Pfister> ;Journal of the National Comprehensive Cancer Network. 2019 Sep 1
170 citations
Women Experience Greater Toxicity With Fluorouracil-Based Chemotherapy for Colorectal Cancer
Jeff A. Sloan, Richard M. Goldberg, Daniel J. Sargent, Delfino Vargas-Chanes, Suresh G. Nair Md, Steven Cha, Paul J. Novotny, Michael A. Poon, Michael J. O'Connell, Ch...> ;Journal of Clinical Oncology. 2002 Mar 15
55 citations
Efficacy and toxicity of adjuvant chemotherapy in elderly patients with colon carcinoma: a 10-year experience of the Geisinger Medical Center.
Farid Fata, M. Ayoub Mirza, G. Craig Wood, Suresh Nair, Amy Law, James G. Gallagher, Neil Ellison, Albert M. Bernath> ;Cancer. 2002 Apr 1
4 citations
Phase II study of methotrexate, vinblastine, doxorubicin, and cisplatin in patients with squamous cell carcinoma of the upper respiratory or alimentary passages of the...
Scott H. Okuno, James A. Mailliard, Vera J. Suman, John H. Edmonson, Edward T. Creagan, Suresh Nair, Ralph Levitt, John W. Kugler> ;Cancer. 2002 Apr 15
30 citations
A phase II trial of docetaxel and CPT-11 in patients with metastatic adenocarcinoma of the esophagus, gastroesophageal junction, and gastric cardia.
Aminah Jatoi, Marisa Tria Tirona, Steven Cha, Steven R. Alberts, Kendrith M. Rowland, Roscoe F. Morton, Suresh G. Nair Md, Carl G. Kardinal, Philip J. Stella, James A....> ;International Journal of Gastrointestinal Cancer. 2002 Jan 1
31 citations
Oral vinorelbine for the treatment of metastatic non-small cell lung cancer in elderly patients: a phase II trial of efficacy and toxicity.
Anne Kanard, Aminah Jatoi, Rene Castillo, Susan Geyer, Thomas K. Schulz, Tom R. Fitch, Kendrith M. Rowland, Suresh G. Nair Md, James E. Krook, John W. Kugler> ;Lung Cancer. 2004 Mar 1
197 citations
An Eicosapentaenoic Acid Supplement Versus Megestrol Acetate Versus Both for Patients With Cancer-Associated Wasting: A North Central Cancer Treatment Group and Nation...
Aminah Jatoi, Kendrith M. Rowland, Charles L. Loprinzi, Jeff A. Sloan, Shaker R. Dakhil, Neil MacDonald, Bruno Gagnon, Paul J. Novotny, James A. Mailliard, Teresita I ...> ;Journal of Clinical Oncology. 2004 Jun 15
12 citations
Phase II evaluation of 96-hour paclitaxel infusion in advanced (recurrent or metastatic) squamous cell carcinoma of the head and neck (E3395): a trial of the Eastern C...
Corey J. Langer, Yi Li, Timothy A. Jennings, Ronald C. DeConti, Suresh G. Nair Md, Roger B. Cohen, Arlene A. Forastiere> ;Cancer Investigation. 2004 Nov 23
60 citations
Randomized phase II trial of three schedules of pemetrexed and gemcitabine as front-line therapy for advanced non-small-cell lung cancer
Cynthia X. Ma, Suresh G. Nair Md, Sachdev P. Thomas, Sumithra J. Mandrekar, Daniel A. Nikcevich, Kendrith M Rowland, Tom R. Fitch, Harold E Windschitl, Shauna L. Hillm...> ;Journal of Clinical Oncology. 2005 Sep 1
95 citations
Should Elderly Non–Small-Cell Lung Cancer Patients Be Offered Elderly-Specific Trials? Results of a Pooled Analysis From the North Central Cancer Treatment Group
Aminah Jatoi, Shauna L. Hillman, Philip J. Stella, Erin M. Green, Alex A. Adjei, Suresh G. Nair Md, Edith A. Perez, Bipinkur Amin, Steven E. Schild, Rene Castillo, Jam...> ;Journal of Clinical Oncology. 2005 Dec 20
Join now to see all